CAMP4 Therapeutics Corp
NASDAQ:CAMP
Income Statement
Earnings Waterfall
CAMP4 Therapeutics Corp
Income Statement
CAMP4 Therapeutics Corp
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
2
+131%
|
3
+99%
|
4
+26%
|
|
| Operating Income | |||||
| Operating Expenses |
(54)
|
(69)
|
(57)
|
(57)
|
|
| Selling, General & Administrative |
(15)
|
(19)
|
(16)
|
(17)
|
|
| Research & Development |
(39)
|
(10)
|
(20)
|
(30)
|
|
| Other Operating Expenses |
0
|
(40)
|
(21)
|
(10)
|
|
| Operating Income |
(53)
N/A
|
(67)
-26%
|
(54)
+19%
|
(53)
+2%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
1
|
1
|
1
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
|
| Total Other Income |
(0)
|
3
|
0
|
0
|
|
| Pre-Tax Income |
(52)
N/A
|
(63)
-22%
|
(51)
+20%
|
(53)
-4%
|
|
| Net Income | |||||
| Tax Provision |
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(52)
|
(63)
|
(51)
|
(53)
|
|
| Net Income (Common) |
(52)
N/A
|
(63)
-22%
|
(51)
+20%
|
(53)
-4%
|
|
| EPS (Diluted) |
-2.66
N/A
|
-3.14
-18%
|
-2.53
+19%
|
-1.94
+23%
|
|